Literature DB >> 32439746

Previously undiagnosed neuroendocrine tumour mimicking breast cancer metastasis to the orbit.

Colin Bacorn1, Esther Kim1, Alexander D Borowsky2, Lily Koo Lin3.   

Abstract

Metastatic neuroendocrine neoplasms to the breast are rare and histopathologic overlap with mammary carcinomas has led to misdiagnosis. We present a case of a middle-aged woman with diplopia and a right medial rectus mass. Metastatic breast cancer was initially suspected based on a history of invasive ductal carcinoma. Detailed immunohistochemistry of the orbital biopsy, gallium-68 dotatate positron emission tomography-CT, and reevaluation of her prior breast specimen, demonstrated that her initial breast carcinoma diagnosis was in error and she was ultimately diagnosed with a previously unknown gastrointestinal neuroendocrine tumour metastatic to both the orbit and breast. This case highlights the challenges of differentiating between metastatic neuroendocrine tumours and invasive mammary carcinomas with neuroendocrine differentiation both in the breast and in the orbit. It is important to recognise the overlap so that a primary neuroendocrine neoplasm is not missed, or treatment significantly delayed. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  oncology; ophthalmology; pathology

Mesh:

Substances:

Year:  2020        PMID: 32439746      PMCID: PMC7247416          DOI: 10.1136/bcr-2020-234629

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

Review 1.  The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.

Authors:  Alireza Mojtahedi; Sanjay Thamake; Izabela Tworowska; David Ranganathan; Ebrahim S Delpassand
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

Review 2.  Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: a systematic literature review.

Authors:  Michael S Broder; David Beenhouwer; Jonathan R Strosberg; Maureen P Neary; Dasha Cherepanov
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

3.  Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies.

Authors:  J Michael Dixon; David A Cameron; Laura M Arthur; Deborah M Axelrod; Lorna Renshaw; Jeremy S Thomas; Arran Turnbull; Oliver Young; Cynthia A Loman; Debbie Jakubowski; Frederick L Baehner; Baljit Singh
Journal:  Adv Ther       Date:  2019-03-11       Impact factor: 3.845

Review 4.  Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT.

Authors:  Yasemin Sanli; Ishan Garg; Asha Kandathil; Tuba Kendi; Maria J Baladron Zanetti; Serkan Kuyumcu; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2018-07-05       Impact factor: 3.959

5.  High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours.

Authors:  Michael S Hofman; Grace Kong; Oliver C Neels; Peter Eu; Emily Hong; Rodney J Hicks
Journal:  J Med Imaging Radiat Oncol       Date:  2012-02       Impact factor: 1.735

6.  Primary Neuroendocrine Tumor of the Orbit Presenting With Acute Proptosis.

Authors:  Preeti J Thyparampil; Michael T Yen; Sadhna Dhingra; Debra J Shetlar; Neda Zarrin-Khameh; Benjamin L Musher
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 Jan/Feb       Impact factor: 1.746

7.  GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland.

Authors:  Hosein Kouros-Mehr; Euan M Slorach; Mark D Sternlicht; Zena Werb
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

8.  Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.

Authors:  Sambit K Mohanty; Stacey A Kim; Deborah F DeLair; Shikha Bose; Anna R Laury; Shefali Chopra; Richard B Mertens; Deepti Dhall
Journal:  Mod Pathol       Date:  2016-04-29       Impact factor: 7.842

9.  Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1.

Authors:  Jerry A Shields; Carol L Shields; Richard Scartozzi
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

10.  Metastases to extraocular muscles from breast cancer: case report and up-to-date review of the literature.

Authors:  Marialuisa Framarino-Dei-Malatesta; Annalisa Chiarito; Federico Bianciardi; Marco Fiorelli; Azzurra Ligato; Giuseppe Naso; Irene Pecorella
Journal:  BMC Cancer       Date:  2019-01-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.